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ne-Year Results of a Randomized Lifestyle Intervention
ancy C.W. ter Bogt, MSc, Wanda J.E. Bemelmans, PhD, Frank W. Beltman, MD, PhD, Jan Broer, MD, PhD,
ndries J. Smit, MD, PhD, Klaas van der Meer, MD, PhD
ackground: Lifestyle interventions targeting prevention of weight gain may have better long-term
success than when aimed at weight loss. Limited evidence exists about such an approach in
the primary care setting.
esign: An RCT was conducted.
etting/
articipants:
Participants were 457 overweight or obese patients (BMI25–40 kg/m2, mean age 56
years, 52% women) with either hypertension or dyslipidemia, or both, from 11 general
practice locations in the Netherlands.
ntervention: In the intervention group, four individual visits to a nurse practitioner (NP) and one
feedback session by telephone were scheduled for lifestyle counseling with guidance of the
NP using a standardized computerized software program. The control group received




Changes in body weight, waist circumference, blood pressure, and blood lipids after 1 year
(dropout 10%). Data were collected in 2006 and 2007. Statistical analyses were
conducted in 2007 and 2008.
esults: There were more weight losers and stabilizers in the NP group than in the general
practitioner usual care (GP-UC) group (77% vs 65%; p0.05). In men, mean weight losses
were 2.3% for the NP group and 0.1% for the GP-UC group (p0.05). Significant
reductions occurred also in waist circumference but not in blood pressure, blood lipids,
and fasting glucose. In women, mean weight losses were in both groups 1.6%. In the NP
group, obese people lost more weight (3.0%) than the non-obese (1.3%; p0.05).
onclusions: Standardized computer-guided counseling by NPs may be an effective strategy to support




The study was registered with the Netherlands Trial Register (NTR), www.trialregister.nl,
study no. TC 1365.















he prevalence of overweight and obesity is in-
creasing in the Netherlands. The upward trend
since 1980 is similar across genders, age groups,
nd degrees of urbanization.1 Prevention of overweight
s a public health priority because overweight and
besity are important risk factors for the development
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© 2009 American Journal of Preventive Medicine • Publishf coronary vascular diseases (partly independent of
lood pressure and cholesterol levels2), type 2 diabetes,
ertain types of cancer, gastrointestinal diseases, and
rthritis.3
According to (inter)national guidelines, persistent
ifestyle changes are necessary for preventing and man-
ging obesity.4,5 Studies on lifestyle interventions have
hown a decrease in the risk of type 2 diabetes6–8 and
ypertension.9 Positive changes in lifestyle may im-
rove health status even without losing weight.10 There
s no clear consensus on the most (cost) effective way to
mplement lifestyle interventions, but attention to both
utrition and physical activity, applying components
rom behavioral therapy, and continuity and intensity
re important aspects.11,12
In the Netherlands, general practitioners (GPs) are
ften responsible for the treatment of hypertension
nd dyslipidemia, and according to their guidelines this
0749-3797/09/$–see front matter















































































Oreatment includes lifestyle advice. However, lack of
ime and knowledge to achieve behavioral changes and
nsufficient continuity of care impede this approach by
Ps.13 Specially trained nurse practitioners (NPs) are
robably better equipped for lifestyle counseling than
Ps and can avoid these barriers.14
Previous lifestyle interventions showed clinically rel-
vant reductions in body weight after 1 year.6 However,
eight regain after initial success is a commonly ac-
nowledged problem. Most of these studies were per-
ormed in obese populations. Further, many studies
ncluded small and mainly female samples and were
ampered by large dropout rates. According to the
HO, additional high-quality trials are needed to
iden our insight into the sustained effectiveness of
ifestyle counseling on body weight.3
To investigate the long-term effects of lifestyle coun-
eling by NPs, and its potential contribution in coun-
eracting the rising trend of overweight and obesity, the
roningen Overweight and Lifestyle (GOAL) study was
tarted in 2006. This RCT included more than 400
verweight or obese patients at relatively low risk for
ardiovascular diseases. An early focus on preventing
progression of) overweight and comorbidities rather
han on weight loss may be more successful in the long
erm. A 3-year follow-up for GOAL is foreseen.
The effects were evaluated after a 1-year follow-up of
omputer-guided lifestyle advice by NPs (intervention
ondition) in comparison to care as usual by GPs
control condition) on body weight and conventional
isk markers. A secondary aim was to identify patient




nitially, 12 general practice locations (varying from one to
even GPs and one to three NPs per location) in the northern
art of the Netherlands were willing to participate. Between
une 2005 and February 2006, a total of 5738 patients (aged
0–70 years) were invited for a screening visit to check on the
nclusion criteria for the GOAL study (chosen at random
00–250 patients for each GP). Almost 25% of the invited
atients participated in the screening (n1378). Presuming a
MI25 kg/m2 for 50% of the GP population,1 the response
ate was almost 50% (the invitational letter discouraged
atients from coming if their BMI was 24 kg/m2). Eligible
atients had to have a BMI between 25 and 40 and either
ypertension or dyslipidemia or both. Hypertension was
efined as mean systolic blood pressure 140 mmHg and
iastolic 90 mmHg (based on two measurements on at least
wo different visits) or current use of blood pressure–lowering
edication, and dyslipidemia was defined as a total serum
holesterol 5.5 mmol/L or low HDL (men: 0.9; women:
1.1 mmol/L) or a ratio of total/HDL cholesterol 6 orurrent use of cholesterol-lowering medication. w
ctober 2009Exclusion criteria were diabetes, hypothyroidism, preg-
ancy, liver or kidney disease, current treatment for malig-
ancy, shortened life expectancy, mental illness, and addic-
ion to alcohol or drugs. After the screening, eligible patients
eceived additional information about the GOAL study
n825) and 75% of them gave written informed consent
n620). Between the screening and the start of the study,
6% of this group dropped out, because of withdrawal of one
eneral practice location from the study (n103); changes in
he Dutch healthcare insurance system (n14); and patient-
elated practical reasons (n46), such as lack of time or
oving to other areas (Figure 1). The GOAL study was
pproved on June 2005 by the Medical Ethics Review Com-
ittee of the University Medical Center Groningen.
aseline Measurements
etween January and July 2006, baseline measurements took
lace, and patients were allocated using computer-generated
andom numbers to the NP (n225) or general practitioner
sual care (GP-UC) group (n232; Figure 1). A structured
hysical exam by a trained research team was accomplished to
easure body weight, length, waist circumference, and blood
ressure. Body weight was measured on an electronic scale
ith subjects wearing light clothing and no shoes, height was
easured using a wall-mounted measuring tape, and waist
ircumference was measured at a level midway between the
owest rib and the iliac crest. Blood pressure was measured
igure 1. Flow of patients through the Groningen Over-
eight and Lifestyle study



















































































2wice and average values were used in analysis. The presence
f cardiovascular risk factors, medication use, and family
istory of disease and overweight or obesity were docu-
ented. Blood samples were collected after an overnight fast
o analyze fasting serum lipids and glucose (in the same
entral laboratory, using conventional and certified labora-
ory assays).
A questionnaire, which was part of the software program
or the lifestyle intervention, was completed via the Internet
r on paper. It contained questions on general characteristics
e.g., education level, gender) and on several issues related to
ody weight (e.g., history of dieting). The Short Question-
aire to Assess Health-Enhancing Physical Activity was used to
etermine physical activity.15 Metabolic syndrome was de-
ned according to criteria from the National Cholesterol
ducation Program’s Adult Treatment Panel III,16 and
ystematic Coronary Risk Evaluation (SCORE) scores to
stimate 10-year risk of fatal cardiovascular disease were
alculated as described by Conroy et al.17 Baseline data were
vailable for all participants, with the following exceptions:
aist circumference (n2); blood analyses (n11); complete
uestionnaires (n11); and items in questionnaire (range of
issing items: 5%–11%). These missing baseline values were
istributed equally between the NP and the GP-UC group.
ntervention
he NPs (contracted by the GPs) followed a specially devel-
ped training program (four sessions of 4 hours each) and
eceived individual instruction about the software program.
he lifestyle intervention consisted of four individual visits
nd one feedback session by telephone in the first year.
uring these contact sessions, the NP was guided by the
tandardized computerized software program that contained
nstructions on lifestyle counseling defined by international
uidelines4,5 and allowed data entry of the measurements.
Table 1 shows the content of the visits. A process evaluation
as performed with a structured questionnaire after the first
hree visits to investigate feasibility of the software program in
aily practice. All NPs had a positive or neutral attitude about
his program and the individualized lifestyle goals for pa-
ients. A large majority (75%) favored future implementation
able 1. Visits (including measurements) and contents of th
ifestyle Study
onth Visit Contents
0 BM Baseline measurement
1 VGP At least one visit at the GP to discuss resu
necessary start treatment and control v
V1 Information on healthy lifestyle, stimulat
extensive conversation on history of sli
weight and a first step in the developm
2 V2 Feedback on lifestyle by critiquing food d
pedometer received in V1) and baselin
(including individual goals)
3 V3 Evaluate the attainability of the goals and
to dietician
5 F1 Evaluate and support changes in lifestyle
8 V4 Evaluate and support changes in lifestyle
2 M1 Measurement after 1 yearM, baseline measurement; F1, feedback moment by telephone by nurse p
P, nurse practitioner (intervention group); VGP, visit with general practi
72 American Journal of Preventive Medicine, Volume 37, Numith regular patients. Average duration of the visits was 35
inutes for the first and second visit (range 15–60 minutes)
nd 25 minutes for the third visit (range 15–40 minutes). The
articipants in the control group were offered one visit
approximately 10 minutes) with their GP to discuss results
rom the screening and thereafter received usual GP care.
ccording to national guidelines, this is low-intensity or
bsent care (regarding focus on lifestyle) for a large majority.
ample-Size Calculation
ower analysis revealed that each study arm should include
45 subjects to observe (with 80% power and a 5% signifi-
ance level) an expected difference in weight loss of 2.8 kg
from 0.2 kg weight change in the GP-UC group to 3.0 kg
eight change in the NP group).6 Estimating a dropout rate
f 15%, a minimum of 334 participants was needed to achieve
45 participants in each study arm. To allow for subgroup
nalyses (at least for gender), the aim was to include 667
atients.
tatistical Analyses
ifferences in baseline characteristics and changes in main
utcome measures after 1 year between the two study groups
ere evaluated with unpaired Student’s t tests for continuous
ariables and chi-square analysis for categoric variables. A
eneral linear model (GLM) was used to adjust for baseline
alues. Further, the GLM was used to examine the relation-
hip between percentage weight loss after 1 year and patients’
haracteristics. Study group, gender, and each characteristic
eparately were entered in the model as fixed variables, and
ge, baseline BMI, and weight change between screening and
aseline were entered as covariates. Thereafter, two models
ere analyzed: in the first one, significant variables from the
LM were used, and in the second model all variables were
sed. Multilevel analysis was used to examine the interaction
etween subjects and general practice location. Differences
etween relevant classes within study groups (number of visits to
Ps and baseline weight class) were evaluated with Student’s t
ests for continuous variables and chi-square analysis for cate-
oric variables. Subjects were categorized into the following
style intervention for the Groningen Overweight and
Group
NP  GP-UC
om baseline measurements and if
ccording to the GPs guidelines
GP-UC
wareness of own lifestyle and body weight,
g and motivation to change lifestyle/lose
f the treatment plan
NP
physical activity (counting steps by
stionnaires; finish treatment plan
NP
cessary change treatment plan and refer NP
if necessary, change individual goals NP
if necessary, change individual goals NP










and,ractitioner; GP-UC, general practitioner usual care (control group);























































Olasses according to percentage of weight change after 1 year:
uccessful weight losers (lost 5%); weight losers (weight loss
rom 1% to 5%); stabilizers (between 1% weight loss and 1%
eight gain); and weight gainers (gained 1%). Differences in
ain outcome variables among these four categories were tested
ith ANOVA and a post hoc Bonferroni test.
The analyses followed the intention-to-treat principle. Re-
ults are primarily presented with exclusion of dropouts and
issing values, adjusting for baseline values. All analyses were
lso performed using baseline observation carried forward for
ropouts. This did not alter the results except for the
ercentage of stabilizers and weight losers, which (naturally) was
igher when copying baseline values (79.1% vs 67.2% in the NP
nd GP-UC group, respectively, after 1 year).
All analyses were performed in 2007 and 2008 using
PSS/PC statistical program version 14.0 for Windows. A
-value 0.05 was considered significant.
esults
aseline Measurements
able 2 shows that there were no differences in the two
tudy groups at baseline except for higher percentages
aving sufficient physical activity and a history of 3










hysical exam and blood analysis
BMI (kg/m2) M (SD)
BMI 30 kg/m2 (cm), M (SD)
Waist circumference for men (cm), M (SD)
Waist circumference for women (cm), M (SD)
Total cholesterol (mmol/L), M (SD)
HDL cholesterol (mmol/L), M (SD)
LDL cholesterol (mmol/L), M (SD)
Fasting glucose (mmol/L), M (SD)
Systolic blood pressure (mmHg), M (SD)
Diastolic blood pressure (mmHg), M (SD)
Hypertension
Using medication for hypertensiona 61/
Dyslipidemia
Using medication for dyslipidemiab 31
SCORE score, M (SD)




3 attempts to lose weight during the past 5 years 33/
30 minutes of moderate-intensity physical
activity 5 days/week
123/
Percentage of participants with hypertension
Percentage of participants with dyslipidemia
Chi-squared NP vs GP-UC group p0.05
P-UC, general practitioner usual care; HDL, high-density lipopro
mol/L, millimoles per liter; NP, nurse practitioner; SCORE, Systemrevious attempts to lose weight in the past 5 years in w
ctober 2009the GP-UC group com-
pared with those in the NP
group. When stratified for
gender, women in the
GP-UC group were older
(aged 57 vs 55 years); had
hypertension more often
(66% vs 54%); and were
sufficiently physically ac-
tive more often (75% vs
58%) (p0.05 for all); in
men there were no signifi-
cant differences in base-
line values between the NP
and the GP-UC group.
Follow-Up Measurement
and Dropout During the
First Year
One year later, the base-
line measurements were
repeated with a total of
416 people (91%). There
were no differences be-
tween these subjects and
the dropouts (n41; 9%)
for age, educational level,
blood pressure, and serum
lipids. Dropouts had a
higher mean value of fast-
ing glucose, higher preva-
lence of hypertension, and
lower prevalence of dyslip-
demia (p0.05; data not shown). Figure 1 presents
easons for dropout.
hanges in main outcome measures for the NP and
P-UC groups after 1 year. After 1 year there were
ore (successful) weight losers and stabilizers in the
P group than in the GP-UC group (77% vs 65%)
p0.05). Mean weight change was 1.9% (SD 4.9) in
he NP group and 0.9% (SD 5.0) in the GP-UC group
p0.05). Mean waist circumference decreased by 2.4
m (SD 7.1) in the NP group and by 1.2 cm (SD 5.9) in
he GP-UC group (p0.07). No significant differences
ccurred for changes in serum lipids or blood pressure.
hanges in body weight stratified for patient character-
stics. Table 3 shows changes in body weight after 1
ear stratified for patient characteristics. In the NP
roup, average weight loss was 2.3% for men and
1.6% for women, whereas in the GP-UC group,
omen lost more weight than men (1.6% vs 0.1%;
0.05). In the NP group, obese participants (BMI 30
g/m2) and participants who visited the NP at least
hree times lost more body weight than participants






















































216 (ith a lower baseline BMI (3.0% vs 1.3%, respec-












































































2ively) and those with zero
o three visits (2.3% vs
0.4%; p0.05).
haracteristics associated with
eight loss. Two GLMs
ere composed; the first
odel (p0.001, R20.08)
howed that weight loss is
ssociated with study group
p0.03); study group X




p0.001); and not with
ender and age. In the second
odel (p0.001, R20.12),
ll variables from Table 3
ere added to the first
odel, but this did not




es were performed, but
he variance resulting from
eneral practice location was
ery low and not significant
intraclass correlation0.02).
hanges in main outcome
ariables separately for gen-
er. The GLM showed that
ender is an effect modi-
er, and Table 3 shows that
eight loss differed accord-
ng to number of NP visits and baseline weight class
obesity versus [moderate] overweight). Table 4 there-
ore presents changes in main outcome variables after 1
ear for the NP and GP-UC groups, separately for men
nd women. For women, no significant differences
ere found between the NP and GP-UC groups al-
hough the percentage of weight losers and stabilizers
ended to be higher in the NP group (73% vs 64%,
espectively; p0.17). For men, changes in body weight
in kilogram and percentage) and waist circumference
ere significantly more favorable in the NP group
ompared with those in the GP-UC group. The percent-
ge of weight losers and stabilizers was higher in the NP
roup than in the GP-UC group (81% vs 65%, respec-
ively; p0.05). Subgroup analyses were also performed
ithin the NP group (also separately for men and
omen) for at least three visits versus less than three
isits and for obese versus non-obese participants. For
omen, no significant differences were found. For
en, changes in body weight (in kilogram and percent-
Table 3. Percentage chang















Attempts to lose weight











aChanges are calculated as th
gender, age, BMI at baseline,
intervention group and one m
bTreatment on overweight an
patient not taken into accoun
*p0.05 NP vs GP-UC group
**p0.05 within NP or GP-UC
GP-UC, general practitioner uge) and waist circumference were significantly more w
74 American Journal of Preventive Medicine, Volume 37, Numavorable in obese men in the NP group compared with
hose in men with a BMI 30 kg/m2 in the NP group.
bese men in the NP group had a greater reduction in
ystolic blood pressure (14 mmHg) than did obese
en in the GP-UC group (5 mmHg; p0.05), in
ddition to lower body weight (in kilogram and per-
entage) and smaller waist circumference (p0.05;
ata not shown).
ssociations between outcome measures and weight
hanges. Except for HDL cholesterol and fasting glu-
ose, the outcome variables differed among the four
ategories of weight change, with successful weight
osers achieving the most favorable and weight gainers the
east favorable results on outcome variables (Table 5).
iscussion
ifestyle counseling using a prestructured software
rogram in a primary care setting succeeded in a
body weight at 1-year follow-up stratified for patients’
oups
NP group GP-UC group
% change in body
weight (95% CI)a n
% change in body
weight (95% CI)a
01 1.9 (2.6,1.2) 215 0.9 (1.5,0.2)*
00 1.9 (2.5,1.2) 214 0.9 (1.5,0.2)*
97 2.3 (3.2,1.3) 100 0.1 (1.1, 0.8)
03 1.6 (2.5,0.6) 114 1.6 (2.5,0.7)**
41 2.2 (3.0,1.4) 127 0.9 (1.7,0.0)
59 1.2 (2.4, 0.0) 87 0.8 (1.8, 0.3)
64 2.5 (3.7,1.3) 64 1.2 (2.4, 0.0)
26 1.7 (2.5,0.8) 136 0.6 (1.5, 0.2)
28 1.3 (2.1,0.5) 136 0.7 (1.5, 0.1)
72 3.0 (4.1,1.9)** 78 1.1 (2.2, 0.0)
80 2.4 (3.5,1.3) 75 1.1 (2.3, 0.1)
73 2.2 (3.3,1.1) 70 0.4 (1.6, 0.8)
32 0.1 (1.6, 1.9) 52 1.0 (2.4, 0.4)
42 0.4 (1.9, 1.0) —
58 2.3 (3.0,1.6)** —
88 2.1 (2.7,1.4) 198 0.7 (1.4,0.1)
12 0.3 (2.5, 3.1) 16 2.2 (4.7, 0.3)
e at 1-year follow-up minus the value at baseline and adjusted for
eight change between screening and baseline (for one man in the
the control group, screening data were missing).
ity indicated according to (inter)national guidelines (motivation of
p























































































Oaintenance in people with moderate overweight,
hich is precisely according to the guidelines.4,5 The
esults were more favorable in men, with significant
ffects on waist circumference, than in women, where
o differences were found between the NP and the
P-UC groups.
Previous research showed that clinically relevant
eight loss of 5% can be achieved after 1 year, but that
ntensive programs are necessary.6 Because of the (rel-
tively) low intensity of the lifestyle counseling strategy,
his intervention was expected to prevent weight gain
r establish marginal weight loss only. In line with this
xpectation, for GOAL, a study group was selected with
ow cardiovascular risk (mean SCORE score 3.4), to aim
rimarily at prevention of weight gain and related
omorbidities in a “healthy population.” Nonetheless,
espite this overall aim and a BMI 25 kg/m2 as a
utoff for inclusion, in the NP group 94% had an
ndication for losing weight according to (inter)na-
ional guidelines on obesity (n188).4,5 In this percent-
ge, the patient’s motivation to lose weight was not




ody weight (kg) 1.4 (4.9)
ody weight (% change) 1.6 (5.6)
aist circumference (cm) 1.5 (6.8)
otal cholesterol (mmol/L) 0.06 (0.8)
DL cholesterol (mmol/L) 0.12 (0.2)
DL cholesterol (mmol/L) 0.02 (0.7)
asting glucose (mmol/L) 0.11 (0.5)
ystolic blood pressure (mmHg) 2.2 (16.5)
iastolic blood pressure (mmHg) 0.2 (8.4)
CORE score 0.46 (1.3)
eight losers and stabilizers,b n (%) 73 (64.0)
Changes are calculated as the value at 1-year follow-up minus the va
Percentage of subjects who gained less than 1% body weight betwe
p0.05 men in NP vs men in GP-UC group after adjustment for ba
P-UC, general practitioner usual care; HDL, high-density lipoprote
ractitioner; SCORE, Systematic Coronary Risk Evaluation
able 5. Changesa in main outcome variables at 1-year follow
Successful weight
losers (n79)
ody weight (kg) 8.1 (3.9)
ody weight (% change) 8.9 (3.7)
aist circumference (cm) 7.9 (7.1)
otal cholesterol (mmol/L) 0.41 (0.9)
DL cholesterol (mmol/L) 0.05 (0.2)
DL cholesterol (mmol/L) 0.26 (0.8)
asting glucose (mmol/L) 0.19 (0.4)
ystolic blood pressure (mmHg) 11.1 (20.2)
iastolic blood pressure (mmHg) 3.6 (10.1)
Changes are calculated as the value at 1-year follow-up assessment m
p-value for linear trend
p0.01 ANOVA with post hoc Bonferroni test with successful weight lose
DL, high-density lipoprotein; LDL, low-density lipoprotein; mmol/L, mil
ctober 2009aken into account. The NPs discussed motivational
spects in the first visit (NP group only), and during
his visit about 75% of the participants expressed a
otivation for losing weight.
In non-indicated and nonmotivated patients, the NP
ifestyle counseling was explicitly aimed at weight stabi-
ization, and no personal weight loss target was dis-
ussed or evaluated. Those with a medical indication
or weight loss lost more weight after 1 year than the
on-indicated, but this difference was not significant
Table 3). This absence of difference may be due to the
act that GOAL is an RCT and all patients gave in-
ormed consent and thereby commitment to the study.
uring the intervention, the average number of NP
isits was almost equal among patients with counseling
ocused on weight loss (n4.5) versus prevention of
eight increase (n4.1). In actual practice, the impact
f patient’s motivation and targeting by NPs will prob-
bly be larger.
The GOAL study is a well designed RCT and its
trengths are the large study population (allowing








1.5 (4.1) 0.0 (3.9) 2.1 (4.8)*
1.7 (4.9) 0.1 (4.0) 2.1 (4.8)*
2.0 (7.8) 0.9 (4.5) 2.8 (6.2)*
0.02 (0.8) 0.03 (0.7) 0.18 (0.6)
0.11 (0.2) 0.05 (0.2) 0.06 (0.2)
0.15 (0.7) 0.12 (0.6) 0.04 (0.6)
0.08 (0.6) 0.05 (0.8) 0.03 (0.6)
5.3 (20.1) 5.3 (12.7) 8.5 (16.8)
0.3 (9.6) 1.3 (7.8) 2.6 (11.2)
0.10 (1.7) 0.07 (1.3) 0.23 (2.8)
75 (72.8) 66 (65.3) 79 (80.6)*
baseline.
eline and 1-year measurement
values
L, low-density lipoprotein; mmol/L, millimoles per liter; NP, nurse







(1.0)* 0.1 (0.4)* 3.3 (2.3)* 0.001
(1.1)* 0.1 (0.5)* 3.8 (2.4)* 0.001
(5.3)* 0.6 (4.3)* 1.9 (5.5)* 0.001
(0.6)* 0.00 (0.7)* 0.12 (0.7)* 0.001
(0.2) 0.09 (0.2) 0.11 (0.2) 0.06
(0.5)* 0.10 (0.6)* 0.20 (0.6)* 0.001
(0.5) 0.08 (0.9) 0.03 (0.6) 0.02
(15.0) 1.7 (13.0)* 0.6 (16.9)* .001
(8.4) 0.2 (9.2) 1.1 (9.3)* .001
















inusrs as the reference category
limoles per liter




























































































2ubgroup analyses) and the low dropout rate after 1
ear (9%). The process evaluation, using a structured
uestionnaire, showed that most NPs favored future
mplementation. Some limitations of the GOAL study
eed to be discussed. There were some baseline differ-
nces between the NP and GP-UC groups (physical
ctivity and attempts to lose weight), but in stratified
nalyses these characteristics were not related to weight
hange after 1 year. Second, regression to the mean
ay be involved owing to the fact that both the GP-UC
nd the NP group patients gained on average 1.0 kg
etween screening and baseline measurements (a pe-
iod of 3–12 months). Weight gain during the pre-study
eriod was significantly inversely related with weight
hange during the first year. However, when also
valuated from the screening on, this intervention
ucceeds in preventing weight gain. Regression to the
ean also cannot account for the gender difference:
he effect of study group was seen in men only (the
ifference of 2.1 kg is in line with the 2.8 kg as
stimated in the power analysis; because of a smaller SD
his difference was significant even with fewer than 145
ale participants). In general, women might have
ore knowledge and experience regarding weight
aintenance (e.g., dieting is more common in wom-
n,18 and more men than women underestimate
heir body weight18,19), and a low-intensity interven-
ion may have limited additional impact in experi-
nced patients.
Third, randomization was done at the patient level,
llowing contamination of research conditions within
he same GP practice. For GOAL, this risk is considered
uite small because there were on average (only) 40
articipants per general practice location (with one to
even GPs per location). On the other hand, NPs were
llied to GPs and were allowed to discuss the patients’
reatment with the GP. However, GPs did not follow the
pecial training and could not use the software pro-
ram (no license, no data available from participants).
eventeen participants from the GP-UC group were
eferred to the NP group following usual procedures in
he practice (the GPs and NPs did not know that the
atients belonged to the control group of the GOAL
tudy). These 17 people did not receive the same
ifestyle counseling as the NP group because the soft-
are program could be used for participants in the NP
roup only. Elimination of these 17 people did not alter
he results.
Until now, most lifestyle interventions have investi-
ated strategies to lose weight, but the first priority
hould be to prevent further weight gain.12,20 A previ-
us low-cost intervention21 and public health messag-
s22 did not succeed in reducing weight gain with age.
recent study that compared three strategies for
chieving weight maintenance after initial weight loss
howed that monthly, brief personal contact provided
odest benefit.23 In the GOAL study, lifestyle changes
76 American Journal of Preventive Medicine, Volume 37, Numre small (consistent with modest weight loss), which
robably makes it easier not to relapse to former
atterns.
Preventing overweight is a public health issue with a
igh priority in many countries. The wider context of
his study was a media climate in the Netherlands that
ocused much attention on overweight and a healthy
ifestyle, and countrywide campaigns were run in the
ame period. This may explain why even the control
roup was quite successful (65% weight losers and
tabilizers). It is an important result that even against
his background of other public health initiatives, life-
tyle counseling in the primary healthcare setting is
ndeed of additional value. This is in line with WHO
tatements that acknowledge the primary healthcare
etting as key for overweight prevention.3 Booth et al.24
howed that GPs gave healthy lifestyle advice to obese
atients rather than to those with a BMI between 23
nd 30 kg/m2, although this latter group might gain
ore health benefits from prevention. Hence, in-
reased awareness among GPs and measurement of
MI is necessary to ensure adequate referral to
Ps. The 3-year results of GOAL, together with cost-
ffectiveness analyses, will determine if this method of
ifestyle advice succeeds in sustained weight reduction
r stabilization in primary care.
he GOAL study was financially supported by the Nether-
ands Organisation for Health Research and Development
Zon-Mw, project no 6200.0016). We are grateful to the
articipating general practices and their patients for their
nthusiasm and cooperation. Thanks to all the students of the
esearch team for performing measurements and helping
ith data collection. We also thank the members of the
ypertension Service Groningen for generating the GOAL
tudy.
No financial disclosures were reported by the authors of
his paper.
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